Loading
Life sciences · Journal article
Annals of Hematology · September 28, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Leukemia remains a critical public health challenge in Asia. We analyzed the epidemiology of five leukemia subtypes (Acute myeloid leukemia, AML; chronic myeloid leukemia, CML; acute lymphoblastic leukemia, ALL; chronic lymphocytic leukemia, CLL; others) across 49 Asian countries/regions from 1990 to 2021, with projections to 2030. Using Global Burden of Disease (GBD) 2021 data, we analyzed age-standardized incidence (ASIR), death (ASDR), disability-adjusted life years (DALYs), and risk factor data from different perspectives. Joinpoint and Bayesian age-period-cohort models were used for trend analysis and prediction. Total leukemia incidence increased by 50.67%, while DALYs ASR decreased by 16.2%. CLL emerged as the predominant subtype, showing positive correlation with SDI ( r = 0.32, p < 0.05). Smoking accounted for 29.0% of CLL deaths in Lebanon, while high BMI contributed to 24.2% of death in Kuwait. ASIR of CLL in middle SDI regions will increase by 1.31%, while in high SDI regions it will decrease by 0.98% by 2030. Leukemia burden in Asia has undergone substantial subtype-specific transitions from 1990 to 2021. These findings highlight heterogeneous epidemiological patterns among leukemia subtypes and the importance of region-specific strategies for leukemia prevention and management.